This site is intended for healthcare professionals
Drug news

Merck Inc., takes a $2.9 billion charge on uprifsobuvir (MK 3682) as the Hepatitis C market diminishes.

Read time: 1 mins
Last updated:25th Feb 2017
Published:25th Feb 2017
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest